drug resistance News
-
2013 List of the CDC’s Biggest Drug-Resistant Threats Discussed in New Video
Today, the IAQ Video Network and Cochrane & Associates announced the release of their latest educational video. Their newest production discusses a list of the biggest drug-resistant microbial threats published by the Centers for Disease Control and Prevention (CDC) in 2013. “Some people are at greater risk than others of superbug infections, but no one can completely avoid the ...
-
Antimicrobial Resistance Diagnostic Challenge Semifinalist
Affinity Biosensors Ultra-Rapid Phenotypical AST by Microbe Mass Measurement has been selected as a Step 1 semifinalist in the Antimicrobial Resistance Rapid, Point-of-Need Diagnostic Test Challenge by the National Institutes of Health (NIH) and the Biomedical Advanced Research and Development Authority (BARDA) of the Office of the Assistant Secretary for Preparedness and Response (ASPR). The ...
-
Creative Proteomics Metabolomics Unveils Drug-Resistant Metabolomics Research Service
Metabolomics, a division of Creative Proteomics, is dedicated to providing cutting-edge LC-MS-based metabolomics services for biomedical research institutions as well as biotechnological and pharmaceutical companies. The company launches the drug-resistant metabolomics research service for oncology research and infectious disease studies regarding drug resistance. Drug therapy is one of the ...
-
CDC Lists Antibiotic Resistance Threats in Puerto Rico and the Rest of the United States
According to the Centers for Disease Control and Prevention (CDC), more than 2.8 million antibiotic-resistant infections occur in the United States each year and more than 35,000 people die as a result. In addition, nearly 223,900 people in the United States required hospital care for Clostridioides difficile (C. diff) infections and at least 12,800 people died from those infections as recently ...
-
Antibiotic Resistance Threats Identified by the CDC and the Importance of Infection Control Procedures and Education
While much of the media’s attention has been focused on the novel coronavirus that spread across the globe this year, SARS-CoV-2 is not the only emerging threat. Just before reports of the initial outbreak of COVID-19 last year, the Centers for Disease Control and Prevention (CDC) published an update to the agency’s first Antibiotic Resistance Threats in the United States (AR Threats ...
-
CARB-X is funding Spanish biotech Vaxdyn to develop a new vaccine to prevent superbug infections that cause life-threatening pneumonia and other deadly infections
CARB-X is awarding Vaxdyn, based in Seville, Spain, up to US$892,000, plus an additional $6.36 million if certain project milestones are met, to develop a new vaccine to prevent life-threatening drug-resistant infections, including pneumonia. Vaxdyn is the first Spanish biotech to be funded by CARB-X, a non-profit partnership investing $500 million in the development of innovative vaccines, ...
-
Solubilization of an hydrophobic API for anti-cancer treatment
Poor water solubility is one of the most significant barrier limiting drug development. Indeed, more than 40% of compounds identified through combinatorial screening programs display poor aqueous solubility, which is associated with poor bioavailability, suboptimal dosing, etc. Adjuvatis uses a safe-by-design technology that allows formulation of APIs with little or no solubility. Adjuvatis ...
By Adjuvatis
-
Deadly Fungal Pathogen Appears to be Developing Drug Resistance
Clinical Infectious Diseases recently published a study that discovered azole-resistance markers in 75% of a small group of aspergillosis patients who had not previously been treated with an azole. Although the study group was small, the findings appear to indicate that there is a growing dissemination of drug-resistant strains of Aspergillus fungi. Azole antifungal agents are a common option ...
-
ClearPoint Neuro Congratulates Neurona Therapeutics on IND Clearance for Neural Cell Therapy NRTX-1001 in Chronic Focal Epilepsy Patients
ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today congratulates partner Neurona Therapeutics on clearance by the U.S. Food and Drug Administration (FDA) of its Investigational New Drug (IND) application to initiate its first-in-human Phase 1/2 clinical trial evaluating the safety and ...
-
CDC Reports California has New ‘Superbug’ Infections
The environmental professionals at Clark Seif Clark (CSC) help medical facilities and infection control professionals combat the growing threat of drug-resistant microbial contaminants. A deadly bacterium with a gene that produces an enzyme that allows it to disable carbapenam antibiotics was recently reported on by the Centers for Disease Control and Prevention (CDC). The enzyme, Klebsiella ...
-
Showcase
A Phase Ii Trial Of Onapristone In Combination With Fulvestrant For Patients With Er-Positive And Her2-Negative Metastatic Breast Cancer After Progression On Endocrine Therapy And Cdk 4/6 Inhibitors
Antiprogestins act as Progesterone Receptor (PgR) antagonists. Novel and promising class of drugs to overcome endocrine resistance associated with ESR1 mutations. SMILE STUDY is a multi-institutional phase II clinical trial to determine the efficacy of an antiprogestin, Onapristone +fulvestrantas second line therapy for patients with HR+/HER2- metastatic breast cancer (MBC). Hypothesis: The ...
-
India`s poultry industry adds to drug resistance
Chickens farmed for meat and eggs in India’s Punjab state harbour high levels of antibiotic-resistant bacteria, says a new Indo-US study. “Misuse of antibiotics in animal farms endangers all of us because it multiplies drug resistance in the environment,” says Ramanan Laxminarayan, director of the Washington-based Center for Disease Dynamics, Economics and Policy, and who ...
By SciDev.Net
-
Infection Control Resources for Candida auris and Other Superbugs
The Centers for Disease Control and Prevention (CDC) established the Antibiotic Resistance Laboratory Network (AR Lab Network) in all 50 states back in 2016. It was designed to help detect new forms of drug resistance from germs like bacteria and fungi that develop the ability to defeat the drugs that were designed to kill them. Drug resistance has become a growing concern, especially in ...
-
MicrobioSeq Releases PCR-based Microbial Antibiotic Resistance Gene Analysis Service
MicrobioSeq represents the microbial genomics division of CD Genomics, headquartered in New York, USA. CD Genomics MicrobioSeq is committed to delivering comprehensive microbial solutions to human health, agriculture, the environment, and industry by characterizing microbiomes and leveraging microorganisms. The company has recently announced the launch of PCR-based microbial antibiotic resistance ...
By CD Genomics
-
Neurona Therapeutics Awarded $8 Million by California Institute for Regenerative Medicine (CIRM) to Support Phase 1/2 Clinical Trial of NRTX-1001 for Chronic Focal Epilepsy
CIRM grant awarded to accelerate clinical trial of NRTX-1001, a promising regenerative neuronal cell therapy in adults with drug-resistant seizures NRTX-1001 is the first human cell therapy candidate to enter clinical investigation for the treatment of epilepsy Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for the treatment of ...
-
Neurona Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
Neurona Therapeutics, a clinical-stage biotherapeutics company advancing restorative neural cell therapies to treat chronic neurological disorders, today announced that Cory Nicholas, Ph.D., Neurona’s president and chief executive officer will present a corporate overview at the H.C. Wainwright BIOCONNECT Virtual Conference, which is being held January 10 -13, 2022. The presentation will ...
-
Sequana Medical secures EUR 10 million loan facility with Kreos Capital
Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), a pioneer in the treatment of drug-resistant fluid overload in liver disease and heart failure, today announces it has entered into a secured loan facility agreement of EUR 10 million with Kreos Capital VI (UK) Limited (“Kreos”). Proceeds from the loan will be used to finance ...
-
Illinois, One of Three States the CDC Reports New ‘Superbug’ Infections
EC2 helps medical facilities find solutions to the growing threat of infections and drug-resistant microbial contaminants with decades of infectious disease and hospital infrastructure knowledge. Last week Fox News reported that new drug resistant ‘superbugs’ have been found in 3 states, including Illinois. Later in the week USA Today published an article entitled ...
-
Drug Resistant Bacteria Found in Nation’s Meat and Poultry
Cinnaminson, NJ, May 2nd, 2011 Last month it was reported that a new study discovered that the bacteria, Staphylococcus aureus, is found widely in the nation’s meat and poultry. The study found that 47% of the 136 samples taken from 26 retail stores in 5 cities across the nation were contaminated with S. aureus. It also reported that 52% of the bacteria were resistant to at least 3 ...
-
Drug Resistant Bacteria May be in Contaminated Turkey Burgers
Yesterday, the Centers for Disease Control and Prevention (CDC) announced that they are, “…collaborating with public health officials in many states and the U.S. Department of Agriculture's Food Safety and Inspection Service (USDA-FSIS) to investigate a multistate outbreak of Salmonella hadar infections. Investigators are using DNA analysis of Salmonella bacteria obtained through ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you